ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 160 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,269,716 | +30.1% | 113,672 | +149.3% | 0.00% | -25.0% |
| Q2 2023 | $975,754 | +54.1% | 45,596 | +191.3% | 0.00% | +33.3% |
| Q1 2023 | $633,048 | -41.8% | 15,654 | -33.1% | 0.00% | -50.0% |
| Q4 2022 | $1,088,382 | -39.5% | 23,396 | -32.6% | 0.01% | -45.5% |
| Q3 2022 | $1,800,000 | +620.0% | 34,699 | +556.6% | 0.01% | +450.0% |
| Q2 2022 | $250,000 | -62.2% | 5,285 | -43.2% | 0.00% | -66.7% |
| Q1 2022 | $662,000 | +4.4% | 9,303 | +9.7% | 0.01% | +20.0% |
| Q4 2021 | $634,000 | +26.8% | 8,479 | +4.7% | 0.01% | -68.8% |
| Q4 2019 | $500,000 | – | 8,096 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |